Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis

M Bairkdar, M Rossides, H Westerlind… - …, 2021 - academic.oup.com
Objectives We aimed to conduct a systematic review and meta-analysis on the incidence
and prevalence of SSc covering the entire literature. Methods This study followed the …

Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment

N Jeganathan, M Sathananthan - Lung, 2020 - Springer
Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features

Y Ito, M Arita, S Kumagai, R Takei, M Noyama… - BMC pulmonary …, 2017 - Springer
Background To identify the prognostic factors for survival in patients with interstitial
pneumonia with autoimmune features (IPAF) who meet the serological domain of the IPAF …

Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature

C Ferri, M Sebastiani, AL Monaco, M Iudici… - Autoimmunity …, 2014 - Elsevier
The clinical spectrum and prognosis of systemic sclerosis (SSc) seem to vary among
patients' populations recruited during different time periods. In order to verify this possible …

Hemodynamic response to treatment and outcomes in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in …

L Chauvelot, D Gamondes, J Berthiller… - Arthritis & …, 2021 - Wiley Online Library
Objective Patients with systemic sclerosis and both pulmonary hypertension and interstitial
lung disease (SSc–PH‐ILD) generally carry a worse prognosis than patients with SSc and …

Pulmonary involvement in systemic sclerosis

A Morales-Cárdenas, C Pérez-Madrid, L Arias… - Autoimmunity …, 2016 - Elsevier
Systemic sclerosis (SSc) is a multi-systemic autoimmune disease that mainly affects the skin,
lungs, gastrointestinal tract, heart and kidneys. Pulmonary disease in patients with SSc is …

Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States

Y Fan, S Bender, W Shi, D Zoz - Journal of managed care & specialty …, 2020 - jmcp.org
BACKGROUND: Although systemic sclerosis (SSc) with interstitial lung disease (SSc-ILD) is
a serious condition and incurs a substantial clinical burden, the epidemiology has not been …

Risk of interstitial lung disease in patients with newly diagnosed systemic autoimmune rheumatic disease: a nationwide, population-based cohort study

KH Ng, DY Chen, CH Lin, WC Chao, YM Chen… - Seminars in Arthritis and …, 2020 - Elsevier
Objective To assess interstitial lung disease (ILD) risk among patients newly diagnosed with
systemic autoimmune rheumatic diseases (SARDs) including rheumatoid arthritis (RA) …

Radiographic fibrosis score predicts survival in systemic sclerosis‐associated interstitial lung disease

R Takei, M Arita, S Kumagai, Y Ito, F Tokioka… - …, 2018 - Wiley Online Library
Background and objective Interstitial lung disease (ILD) is a common pulmonary
manifestation of systemic sclerosis (SSc). It is unknown whether radiographic fibrosis score …

Cardiovascular risk factors and atherosclerotic cardiovascular events among incident cases of systemic sclerosis: results from a population-based cohort (1980-2016)

RD Kurmann, AS Sandhu, CS Crowson… - Mayo Clinic …, 2020 - Elsevier
Objective To characterize cardiovascular (CV) risk factors and outcomes among incident
cases of systemic sclerosis (SSc) in a population-based cohort. Methods Medical records of …